Review
Accepted on 22 Jul 2024
Regulation mechanism of microRNAs in cardiac cells-derived exosomes in cell crosstalk
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1399850
Type at least 3 characters
23,303 articles
Articles
Original Research
Accepted on 22 Jul 2024
The Approach of Norm Balance in Predicting Pharmacists' Intention to Collaborate with Physicians to Improve Medication Therapy
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1375529
Original Research
Accepted on 22 Jul 2024
The galectin-3 inhibitor selvigaltin reduces liver inflammation and fibrosis in a high fat diet rabbit model of metabolic-associated steatohepatitis
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1430109
Case Report
Accepted on 22 Jul 2024
A Case Report: Pathological Complete Response to Neoadjuvant Lorlatinib for Epithelioid Inflammatory Myofibroblastic Sarcoma with EML4-ALK Rearrangement
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1401428
Original Research
Accepted on 22 Jul 2024
Optimization of culture conditions for endophytic bacteria in mangrove plants and isolation and identification of bacteriocin
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1429423
Case Report
Accepted on 22 Jul 2024
Toxic Epidermal Necrolysis Caused by Phenobarbital: A Case Report and Literature Review
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1433506
Clinical Trial
Accepted on 22 Jul 2024
No QTc prolongation with CDK 4/6 inhibitor FCN-437c: Results of a Concentration-QTc analysis from a Dedicated Study in Adult Healthy Subjects
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1433663
Review
Accepted on 22 Jul 2024
Pharmacological Effects of Astragalus Polysaccharides in Treating Neurodegenerative Diseases
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1449101
Review
Accepted on 22 Jul 2024
Strategies for the Development of Stimuli-Responsive Small Molecule Prodrugs for Cancer Treatment
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1434137
Original Research
Published on 22 Jul 2024
Synthesis, characterization, and mechanistic insights into the enhanced anti-inflammatory activity of baicalin butyl ester via the PI3K-AKT pathway
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1417372
Original Research
Published on 22 Jul 2024
Pan-cancer analyses reveal the molecular and clinical characteristics of TET family members and suggests that TET3 maybe a potential therapeutic target
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1418456
Review
Published on 22 Jul 2024
Investigating the value of urinary biomarkers in relation to lupus nephritis histopathology: present insights and future prospects
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1421657
Review
Published on 22 Jul 2024
An overview of traditional smoking cessation interventions and E-cigarettes
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1293062
Review
Published on 22 Jul 2024
Molecular biomarkers of leukemia: convergence-based drug resistance mechanisms in chronic myeloid leukemia and myeloproliferative neoplasms
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1422565
Review
Published on 22 Jul 2024
Targeting dysregulated intracellular immunometabolism within synovial microenvironment in rheumatoid arthritis with natural products
in Ethnopharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1403823
Review
Published on 22 Jul 2024
Prospects of compounds of herbal plants as anticancer agents: a comprehensive review from molecular pathways
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1387866